Spravato treatment is contraindicated in patients with the following conditions:
Aneurysmal vascular disease (including thoracic and abdominal aorta, intracranial, and peripheral arterial vessels) or arteriovenous malformation
History of intracerebral hemorrhage
Hypersensitivity to Esketamine, ketamine, or any of the excipients.